Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia

Hyun Joon Paek1, Courtney Kim1, Stuart K Williams1

  • 1Hyun Joon Paek, Courtney Kim, Biologics, Tissue Genesis Institute, LLC, Honolulu, HI 96813, United States.

Insights

Adipose-derived stem cells (ADSCs) offer a promising alternative for diabetes treatment by differentiating into insulin-producing cells. ADSCs also enhance pancreatic islet transplantation success through improved vascularization and reduced inflammation.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Stem Cell Biology

Background:

  • Diabetes mellitus affects millions globally, with current treatments limited by organ availability.
  • Existing therapies like insulin injections and islet transplantation face challenges such as organ scarcity and immune rejection.
  • Stem cell-based therapies offer a potential alternative for beta cell replacement.

Purpose of the Study:

  • To explore the potential of adipose-derived stem cells (ADSCs) as an alternative source for insulin-producing cells.
  • To investigate the capacity of ADSCs to support and improve pancreatic islet transplantation outcomes.
  • To highlight the therapeutic advantages of ADSCs in managing diabetes.

Main Methods:

  • Utilizing multipotent mesenchymal stem cells derived from adipose tissue.
  • Differentiating adipose-derived stem cells (ADSCs) into insulin-producing cells.
  • Evaluating ADSCs' potential for vasculogenesis, angiogenesis, and immunomodulation.

Main Results:

  • Adipose-derived stem cells (ADSCs) can be obtained non-invasively and differentiate into insulin-producing cells.
  • ADSCs promote vasculogenesis and angiogenesis, aiding donor islet engraftment.
  • ADSCs exhibit anti-inflammatory and immunomodulatory properties beneficial for transplantation.

Conclusions:

  • Adipose-derived stem cells (ADSCs) represent a viable and promising source for diabetes regenerative therapy.
  • ADSC co-transplantation with pancreatic islets can significantly improve transplant success rates.
  • Further research into ADSC-based therapies holds substantial potential for advancing diabetes treatment.

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23